insights_auto
Why is 1TWST down 2.38%?
Dive Deeperchevron_right
1TWST:BIT
Twist Bioscience Corp
€172.60
arrow_downward
-2.38%(-4.20) 1D
Oct 2, 5:26:00 PM GMT+2 · EUR
search
All symbols
| Symbol | Price | Change | % Change |
|---|
insights_autoGenerating top insights for 1TWST...
Open
€169.40
High
€172.70
Low
€169.40
Mkt. cap
10.59B
Avg. vol.
80.00
Volume
21.00
52-wk high
€172.70
52-wk low
€21.70
No. of employees
979
Open
€169.40
High
€172.70
Low
€169.40
Mkt. cap
10.59B
Avg. vol.
80.00
Volume
21.00
52-wk high
€172.70
52-wk low
€21.70
No. of employees
979
News stories
From web sources and news partners
Investing.com Nigeria
·
9 hours ago
Form 144 Twist Bioscience Corp For: 10 October By Investing.com
Stock Titan
·
23 hours ago
A proposed 2,462-share sale at Twist Bioscience (TWST) includes shares to cover an equity-award tax bill.
TipRanks
·
2 days ago
Why Twist Bioscience’s Hot Stock Is Suddenly Sinking
Investing.com
·
2 days ago
Jefferies initiates Twist Bioscience stock at Hold on valuation
Profile
Twist Bioscience is a public biotechnology company based in South San Francisco that manufactures synthetic DNA and DNA products for customers in a wide range of industries. Twist was founded in 2013 by Emily Leproust, Bill Banyai, and Bill Peck.
The company was represented by Leproust at a March 2021 tabletop exercise at the Munich Security Conference simulating an outbreak of weaponized monkeypox.
In May 2021, Twist Bioscience and Genome Project-Write launched a new CAD platform for whole genome design. The CAD will automate workflows to enable collaborative efforts critical for scale-up from designing plasmids to megabases across entire genomes. Wikipedia
About Twist Bioscience Corp